VALIANTLAB.BO
Valiant Laboratories Limited$68.98
Jun 18, 2026
Market cap
$3.72B
52w range
—
P / E
—
EPS · FY 2026
$-0.51
Volume
—
Revenue · FY 2026
$2.37B
Explain this page
Arphra AIPlain-English read on Valiant Laboratories Limited’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Candlestick · 1Y
Open in chart workstation →VALIANTLAB.BO
68.98+19.86%H 83.25L 50.00MA50 65.70MA200 —Avg vol 4K
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Real Estate+1.01%
- Consumer Cyclical+0.94%
- Energy+0.84%
- Consumer Defensive+0.82%
- Financial Services+0.23%
- Basic Materials-0.11%
- Healthcare-0.18%
- Communication Services-0.18%
- Industrials-0.47%
- Technology-0.85%
- Utilities-1.03%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - Specialty & Generic+1.99%
- Software - Services+9.60%
- Broadcasting+8.34%
- Travel Services+7.87%
- Computer Hardware+4.56%
- Oil & Gas Energy-3.54%
- Biotechnology+3.28%
- Electrical Equipment & Parts-3.25%
- Semiconductors-2.12%
- Communication Equipment+2.06%
- REIT - Healthcare Facilities+2.01%
- Consulting Services-1.97%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for VALIANTLAB.BO.
Peers
No peer list available for VALIANTLAB.BO.
Total assets
$4.64B
Total debt
$462.12M
Cash & equiv
$70.56M
Operating CF
-$129.98M
Free cash flow
-$471.97M
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $2.37B | $3.5M | -$32.68M | $-0.51 | -1.38% |